| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
060
|
Date of Entry 05/29/2023
|
|
FR Recognition Number
|
6-488
|
| Standard | |
ASTM F1671/F1671M-22
Standard Test Method for Resistance of Materials Used in Protective Clothing to Penetration by Blood-Borne Pathogens Using Phi-X174 Bacteriophage Penetration as a Test System |
|
Scope/Abstract1.1 This test method is used to measure the resistance of materials used in protective clothing to penetration by blood-borne pathogens using a surrogate microbe under conditions of continuous liquid contact. Protective clothing material pass/fail determinations are based on the detection of viral penetration.
1.1.1 This test method is not always effective in testing protective clothing materials having thick, inner liners which readily absorb the liquid assay fluid.
1.2 This test method does not apply to all forms or conditions of blood-borne pathogen exposure. Users of the test method should review modes for worker/clothing exposure and assess the appropriateness of this test method for their specific applications.
1.3 This test method has been specifically defined for modeling the viral penetration of Hepatitis (B and C) and Human Immunodeficiency Viruses transmitted in blood and other potentially infectious body fluids. Inferences for protection from other pathogens must be assessed on a case-by-case basis.
1.4 This test method addresses only the performance of materials or certain material constructions (for example, seams) used in protective clothing and determined to be viral resistant. This test method does not address the design, overall construction and components, or interfaces of garments or other factors which may affect the overall protection offered by the protective clothing.
... |
|
| Extent of Recognition
|
Rationale for Recognition
| This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
| FDA recognition of ASTM F1671/F1671M-13 [Rec# 6-306] will be superseded by recognition of ASTM F1671/F1671M-22 [Rec# 6-488]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 6-306] until July 6, 2025. After this transition period, declarations of conformity to [Rec# 6-306] will not be accepted. |
|
Public Law, CFR Citation(s) and Procode(s)*
| Regulation Number |
Device Name |
Device Class |
Product Code |
| §878.4040 |
Gown, Surgical
|
Class 2
|
FYA
|
| §878.4040 |
Gown, Isolation, Surgical
|
Class 2
|
FYC
|
| §878.4040 |
Non-Surgical Gown
|
Class 1
|
OEA
|
| §878.4040 |
Gown, Non-Sterile, Non-Isolation, Intended To Provide Moderate Or High Barrier Protection
|
Class 2
|
QPC
|
| §878.4040 |
Medical Gowns With Chemotherapy Labeling Claims - Tested For Use With Chemotherapy Drugs
|
Class 2
|
QSO
|
|
Relevant FDA Guidance and/or Supportive Publications*
1. Guidance on Premarket Notification [510(k)] Submissions for Surgical Gowns and Surgical Drapes, issued August 1993.
2. Premarket Notification Requirements Concerning Gowns Intended for Use in Health Care Settings - Guidance for Industry and Food and Drug Administration Staff, issued December 2015.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contact
|
| Standards Development Organization
|
FDA Specialty Task Group (STG)
| General Plastic Surgery/General Hospital |
|
| *These are provided as examples and others may be applicable. |
